Sign in

CIK 0001107421

  • Non-accelerated filer
  • Smaller reporting company

Alaunos Therapeutics, Inc.

Sign in to watch
Ticker
TCRT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
841475642
Phone
+1 346-355-4099
Business address
501 E LAS OLAS BLVD, SUITE 300, FORT LAUDERDALE, FL, 33301
Former names
ZIOPHARM ONCOLOGY INC, EASYWEB INC
  1. 3 Insider Initial Statement of Ownership
  2. 4 Open-market buy Director bought 1,440,000 shares at $8.75 ($12,600,000)
  3. 4 Grant or award Director acquired 16,707 shares (grant or award)
  4. 4 Shares withheld for taxes Director gave up 4,098 shares (to pay taxes)
  5. 4 Shares withheld for taxes Director gave up 8,633 shares (to pay taxes)
  6. 4 Shares withheld for taxes CEO gave up 34,261 shares (to pay taxes)
  7. 4 Shares withheld for taxes Vice Pres., Treasurer, & CAO gave up 4,690 shares (to pay taxes)
  8. 4 Shares withheld for taxes Director gave up 9,866 shares (to pay taxes)
  9. 4 Shares withheld for taxes Director gave up 7,632 shares (to pay taxes)
  10. 4 Derivatives Options or other derivatives
  11. 4 Shares withheld for taxes EVP, CLO, and Secretary gave up 7,192 shares (to pay taxes)
  12. 4 Option exercise Director acquired 30,583 shares (option exercise)
  13. 4 Option exercise Director acquired 50,000 shares (option exercise)
  14. 4 Other disposition Director disposed of 26,366 shares (other)
  15. 4 Shares withheld for taxes EVP, CLO, and Secretary gave up 14,600 shares (to pay taxes)
  16. 4 Option exercise CEO acquired 268,653 shares (option exercise)
  17. 4/A Shares withheld for taxes Director gave up 2,047 shares (to pay taxes)
  18. 4/A Shares withheld for taxes Director gave up 2,927 shares (to pay taxes)
  19. 4 Shares withheld for taxes Director gave up 5,854 shares (to pay taxes)
  20. 4 Grant or award Director acquired 18,818 shares (grant or award)

Page 14 of 24 · 465 filings